Standard Biotools (LAB) Gross Profit Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 8.95% |
| 10 | Standard Biotools | 254.42 Mn | -222.29 Mn | 10.54 Mn | -0.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.88% |
| Mar 31, 2026 | 2.34% |
| Dec 31, 2025 | 0.22% |
| Sep 30, 2025 | -21.79% |
| Jun 30, 2025 | 2.45% |
| Mar 31, 2025 | -54.32% |
| Dec 31, 2024 | -14.97% |
| Sep 30, 2024 | 8.71% |
| Jun 30, 2024 | -23.73% |
| Mar 31, 2024 | 96.95% |
| Dec 31, 2023 | 19.61% |
| Sep 30, 2023 | 20.98% |
| Jun 30, 2023 | 207.25% |
| Mar 31, 2023 | -50.03% |
| Sep 30, 2022 | -83.11% |
| Jun 30, 2022 | -92.60% |
| Mar 31, 2022 | 16.30% |
| Sep 30, 2021 | 162.49% |
| Jun 30, 2021 | 406.17% |
| Mar 31, 2021 | 62.52% |